Researchers Kalyani Chaubey et al. recently discovered that the drug P7C3-A20 is able to reverse the brain pathology and cognitive decline of advanced Alzheimer’s disease in mice.

Researchers Liam J. Sherwood et al. recently developed the Fear Avoidance after Concussion Tool (FACT), the first validated patient-reported outcome measure for evaluating fear avoidance following concussion

The Sunflower symbol for invisible disabilities is blossoming around the United States and the world, according to a recent article written by Lauren Fetten and published by Being Patient.

A recent study published in Brain Injury by Jonathan Santana and colleagues found that pediatric concussion characteristics differ significantly with age.

A recent retrospective cohort analysis published in BMJ Open found that concussion patients have a 49% higher long-term risk of being in a serious motor vehicle crash after injury compared to patients with an ankle sprain.

Researchers Frank Peacock et al. found nine clinical characteristics associated with an increased risk of a concussion patient still having symptoms 30 days after a mild TBI (mTBI).

Christina Caron explores a technique called Cognitive Shuffling as a potential tool for those who struggle to fall asleep at night in a 2025 article for The New York Times.

A recent study published in BMC Psychiatry found that post-concussion symptom severity, injury severity, and psychological resilience can predict the risk of post-concussion depression in adults.

A study published in Frontiers in Neurology found that non-invasive vagus nerve stimulation (nVNS) is associated with improvements in persisting concussion symptoms across cognitive, affective (mood), somatic (physical), and vestibular (balance) domains.

A recent study published in Nature found that multiple years of repetitive head impacts can cause changes in the brain at the cellular level that precede and may underlie clustering of hyperphosphorylated tau protein, a key marker of chronic traumatic encephalopathy (CTE).

A new Clinical Practice Guideline (CPG) on traumatic brain injury care was recently published in the Journal of Neurotrauma.

A “proof-of-concept” study found that 8-10 weeks of at-home treatment with a transcranial photobiomodulation device resulted in improvements in cognitive function in adults exposed to repetitive head acceleration events.

An article published by the Brain Health Association of America suggests that practicing regular self-compassion leads to the mitigation of mental health issues after a traumatic brain injury (including concussion).

A group of researchers at Xi'an Jiaotong University found that four weeks of acupuncture, starting a week after a concussion, reduced concussion symptoms and improved brain tissue (white matter) integrity.

A study conducted by Daisy Zamora et al. discovered a correlation between a diet consisting of high omega-3 fatty acids and low omega-6 linoleic acids (the diet is labeled “H3L6”) and a reduction in persistent post-traumatic headaches (pPTH).

A recent clinical study led by Rahimi et al. examined the effects of sub-symptom threshold aerobic exercise on executive function in individuals recovering from sport-related concussions (SRC).

A study published in Nature found that hyperbaric oxygen therapy (HBO2) improved persistent symptoms in people with brain injuries, including those with mild traumatic brain injuries.

A clinical practice guideline (CPG) published in the New England Journal of Medicine recommends 24–72 hours of relative rest after a concussion, followed by a gradual return to activity and exercise.

Russell & colleagues’ 10-year epidemiological investigation into the medical records of Cirque du Soleil performers, published in Sports Health: A Multidisciplinary Approach, identified a concussion incidence rate among Cirque artists numerically comparable to varsity and professional non-contact athletics, unique mechanisms of injury in circus that remain overlooked, and significant time loss before safe return to performance.

A scientific abstract presented at the American Headache Society 67th Annual Scientific Meeting highlights that a combination of early interventions and therapies is crucial for alleviating symptoms in pediatric patients (ages 5-17) with new daily persistent headaches (NDPH).